Statins (HMGCR inhibitors) have been proposed as treatment for neurogenerative diseases including SNHL notably through anti-atherosclerotic effect on cochlear artery and anti-inflammatory activity. Here, HMGCR is linked to sensorineural hearing loss disorder.